Angola vs Peru: The number of people with susceptibility test result for rifampicin
Angola
10,250
in 2021
Peru
13,453
in 2021
Angola rank
21st
Peru rank
18th
The number of people with susceptibility test result for rifampicin over time
- Angola
- Peru
How they compare
Peru currently reports 13,453 against 10,250 in Angola, a difference of 3,203.
That makes Peru's figure about 1.3 times Angola's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Peru ahead.
Angola ranks 21st and Peru ranks 18th of 155 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9,969 | 13,485 | 3,516 | Peru |
| 2020s | 5,672 | 11,518 | 5,846 | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Peru?
- Peru, at 13,453 against 10,250 in Angola as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Peru?
- 3,203, with Peru ahead.
- How many years of comparable data are there for Angola and Peru?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Peru rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 21st and Peru ranks 18th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.